Open AccessSubmicron loteprednol etabonate ophthalmic gel 0.38% for the treatment of inflammation and pain after cataract surgery
Author(s) -
Raymond Fong,
Bruce E. Silverstein,
James H. Peace,
Jon I. Williams,
Jason L. Vittitow
Publication year - 2018
Publication title -
journal of cataract and refractive surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.678
H-Index - 142
eISSN - 1873-4502
pISSN - 0886-3350
DOI - 10.1016/j.jcrs.2018.06.056
Subject(s) - medicine , tolerability , intraocular pressure , visual acuity , cataract surgery , ophthalmology , randomized controlled trial , adverse effect , population , surgery , environmental health
To assess the safety and efficacy of a 0.38% submicron formulation of loteprednol etabonate (LE) gel for the treatment of postoperative inflammation and pain after cataract surgery.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom